LT3280721T - Azoto iprito darinių gavimo būdas - Google Patents

Azoto iprito darinių gavimo būdas

Info

Publication number
LT3280721T
LT3280721T LTEP16722854.3T LT16722854T LT3280721T LT 3280721 T LT3280721 T LT 3280721T LT 16722854 T LT16722854 T LT 16722854T LT 3280721 T LT3280721 T LT 3280721T
Authority
LT
Lithuania
Prior art keywords
iprite
derivatives
obtaining nitrogen
nitrogen
obtaining
Prior art date
Application number
LTEP16722854.3T
Other languages
English (en)
Inventor
Niklas Håkan WAHLSTRÖM
Johan Anders WENNERBERG
Original Assignee
Oncopeptides Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncopeptides Ab filed Critical Oncopeptides Ab
Publication of LT3280721T publication Critical patent/LT3280721T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/06—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/14—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Seasonings (AREA)
  • Compounds Of Unknown Constitution (AREA)
LTEP16722854.3T 2015-05-08 2016-05-06 Azoto iprito darinių gavimo būdas LT3280721T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1507903.1A GB201507903D0 (en) 2015-05-08 2015-05-08 Process for preparation of nitrogen mustard derivatives
PCT/EP2016/060242 WO2016180740A1 (en) 2015-05-08 2016-05-06 Process for preparation of nitrogen mustard derivatives

Publications (1)

Publication Number Publication Date
LT3280721T true LT3280721T (lt) 2020-12-28

Family

ID=53489337

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP16722854.3T LT3280721T (lt) 2015-05-08 2016-05-06 Azoto iprito darinių gavimo būdas

Country Status (24)

Country Link
US (1) US10287316B2 (lt)
EP (1) EP3280721B1 (lt)
JP (1) JP6862354B2 (lt)
KR (1) KR102593509B1 (lt)
CN (1) CN107810189B (lt)
AU (1) AU2016260693B2 (lt)
BR (1) BR112017024051A2 (lt)
CA (1) CA2983559C (lt)
CY (1) CY1123468T1 (lt)
ES (1) ES2826401T3 (lt)
GB (1) GB201507903D0 (lt)
HR (1) HRP20201616T1 (lt)
HU (1) HUE051196T2 (lt)
IL (1) IL255428B (lt)
LT (1) LT3280721T (lt)
MX (1) MX388420B (lt)
PL (1) PL3280721T3 (lt)
PT (1) PT3280721T (lt)
RS (1) RS60952B1 (lt)
RU (1) RU2715233C2 (lt)
SI (1) SI3280721T1 (lt)
SM (1) SMT202000550T1 (lt)
WO (1) WO2016180740A1 (lt)
ZA (1) ZA201707226B (lt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020079165A1 (en) 2018-10-18 2020-04-23 Oncopeptides Ab Compounds containing deuterium
JP7475635B2 (ja) * 2020-01-30 2024-04-30 公立大学法人大阪 含窒素化合物およびその製造方法、ならびに該含窒素化合物を含む光機能性材料
CN112546969B (zh) * 2020-12-07 2022-12-23 安徽贝克制药股份有限公司 催化加氢连续生产装置和利托那韦中间体的制备方法
EP4347615B1 (en) 2021-06-01 2025-05-21 Synthon B.V. Process for making melflufen or a salt thereof
GB202204171D0 (en) 2022-03-24 2022-05-11 Oncopeptides Ab Novel formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6992207B2 (en) * 2000-06-13 2006-01-31 Oncopeptides Ab Melphalan derivatives and their use as cancer chemotherapeutic drugs
SE0002202D0 (sv) 2000-06-13 2000-06-13 Karolinska Innovations Ab New peptides
EP2305255B1 (en) * 2001-12-03 2012-08-22 Bayer HealthCare LLC Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
TW200615273A (en) * 2004-11-10 2006-05-16 Nicholas Piramal India Ltd Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
BRPI0611285A2 (pt) * 2005-05-20 2010-08-31 Elan Pharm Inc derivados de imidazolona fenilalanina
CN100491339C (zh) 2007-04-20 2009-05-27 苏州市立德化学有限公司 一种抗肿瘤药物美法仑的合成工艺
MX2011003751A (es) * 2008-10-08 2011-04-27 Cephalon Inc Procesos para preparar bendamustina.
SI3228319T1 (sl) 2011-04-28 2020-10-30 Oncopeptides Ab Liofiliziran pripravek citotoksičnih dipeptidov
US20130079383A1 (en) * 2011-07-13 2013-03-28 Arrowhead Research Corporation Lipid Compounds Targeting VLA-4
JP6284945B2 (ja) 2012-10-26 2018-02-28 オンコペプティデス エービーOncopeptides AB メルファランフルフェナミドの凍結乾燥製剤
EP2970102B1 (en) * 2013-03-11 2019-05-08 Biophore India Pharmaceuticals Pvt. Ltd. An improved process for the synthesis of melphalan and the hydrochloride salt
ITMI20130896A1 (it) * 2013-05-31 2014-12-01 Farmabios Spa Processo di purificazione di melphalan

Also Published As

Publication number Publication date
BR112017024051A2 (pt) 2018-07-24
IL255428B (en) 2021-07-29
RU2017142725A3 (lt) 2019-09-09
MX388420B (es) 2025-03-19
RS60952B1 (sr) 2020-11-30
AU2016260693B2 (en) 2020-05-14
KR102593509B1 (ko) 2023-10-24
RU2715233C2 (ru) 2020-02-26
SI3280721T1 (sl) 2020-11-30
GB201507903D0 (en) 2015-06-24
PT3280721T (pt) 2020-10-20
ZA201707226B (en) 2019-01-30
JP2018515512A (ja) 2018-06-14
SMT202000550T1 (it) 2020-11-10
AU2016260693A1 (en) 2017-11-23
HRP20201616T1 (hr) 2021-01-08
PL3280721T3 (pl) 2021-01-25
CA2983559A1 (en) 2016-11-17
EP3280721A1 (en) 2018-02-14
CN107810189B (zh) 2022-02-11
MX2017014292A (es) 2018-03-07
IL255428A0 (en) 2017-12-31
CA2983559C (en) 2023-11-07
KR20180005214A (ko) 2018-01-15
CY1123468T1 (el) 2022-03-24
RU2017142725A (ru) 2019-06-10
EP3280721B1 (en) 2020-07-22
US20180148473A1 (en) 2018-05-31
NZ736564A (en) 2023-10-27
HK1250732A1 (en) 2019-01-11
US10287316B2 (en) 2019-05-14
WO2016180740A1 (en) 2016-11-17
ES2826401T3 (es) 2021-05-18
HUE051196T2 (hu) 2021-03-01
CN107810189A (zh) 2018-03-16
JP6862354B2 (ja) 2021-04-21

Similar Documents

Publication Publication Date Title
PL3325443T3 (pl) Sposób otrzymywania pridopidyny
PL3167096T3 (pl) Dwuetapowy sposób nanoszenia
DK3319956T3 (da) Substituerede oxopyridinderivater
LT3303334T (lt) Tirozinkinazės inhibitoriai
EP3615539A4 (en) 2-AMINO-QUINOLEINE DERIVATIVES
MA44474A (fr) Nouveaux inhibiteurs de la ferroportine
IL272851A (en) Methods of using dipivefrin
DK3294885T3 (da) Fremgangsmåde til at fremstille rna
DK3473621T3 (da) Fremgangsmåde til fremstilling af diphenylmethan-derivat
PL3457851T3 (pl) Pochodne sobetiromu
EP3386505A4 (en) AZA-BENZIMIDAZOLINHIBITORS OF PAD4
EP3356447A4 (en) INHIBITORS OF MENACHINONE BIOSYNTHESIS
LT3288944T (lt) Imidazopirazinonai, kaip pde1 inhibitoriai
DK3341379T3 (da) EZH2-hæmmere
IL253889A0 (en) Detection of brain injury
LT3661562T (lt) Cys-mab konjugavimo būdas
DK3283210T3 (da) Fremgangsmåde
LT3371168T (lt) Indolin-2-ono dariniai
PL3393468T3 (pl) Metody leczenia niedoboru odporności
FR3023290B1 (fr) Derives de flavaglines
PL3630738T3 (pl) Sposób wytwarzania ozanimodu
DK3346990T3 (da) Fremgangsmåde til stråleformaling
PT3143018T (pt) Derivados da caboxamida
IL313083A (en) Tralipressin compounds and methods of using them
DK3360863T3 (da) Etomidatderivat og mellemprodukt, fremgangsmåde til fremstilling og anvendelse deraf